Geode Capital Management, LLC Dyne Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,887,329 shares of DYN stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,887,329
Previous 1,859,413
1.5%
Holding current value
$15.4 Million
Previous $66.8 Million
33.43%
% of portfolio
0.0%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding DYN
# of Institutions
212Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$65.5 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$60.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$60.3 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$54.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$52.1 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $423M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...